Aethlon Medical, Inc. (AEMD) financial statements (2020 and earlier)

Company profile

Business Address 9635 GRANITE RIDGE DRIVE, SUITE 100
SAN DIEGO, CA 92123
State of Incorp. NV
Fiscal Year End March 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4472211
Cash and cash equivalents4472211
Receivables0 0 000
Other undisclosed current assets0000000
Total current assets:4472211
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment0000000
Intangible assets, net (including goodwill)0000000
Intangible assets, net (excluding goodwill)0000000
Deposits noncurrent assets0000   
Other noncurrent assets    0  
Other undisclosed noncurrent assets     00
Total noncurrent assets:0000000
TOTAL ASSETS:5472312
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities0000002
Accounts payable0000001
Interest and dividends payable     01
Deferred revenue0
Debt01    0
Derivative instruments and hedges, liabilities      11
Due to related parties0000001
Other liabilities0100002
Other undisclosed current liabilities     (0)0
Total current liabilities:12011116
Noncurrent Liabilities
Long-term debt and lease obligation0 11101
Long-term debt, excluding current maturities  11101
Operating lease, liability0
Total noncurrent liabilities:0 11101
Total liabilities:12111116
Stockholders' equity
Stockholders' equity attributable to parent426121(15)
Common stock0000000
Additional paid in capital11410810694888260
Accumulated deficit(110)(106)(99)(94)(87)(82)(75)
Stockholders' equity attributable to noncontrolling interest(0)(0)(0)(0)(0)00
Total stockholders' equity:426121(15)
TOTAL LIABILITIES AND EQUITY:5472312

Income statement (P&L) ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
Revenue, net00111
Other income     0
Gross profit:1000112
Operating expenses(6)(6)(5)(6)(5)(5)(5)
Other operating expense, net
(Other Expenses)
     (3)(0)
Other undisclosed operating income     30
Operating loss:(6)(6)(5)(6)(4)(4)(3)
Nonoperating income0     10
Interest and debt expense(0)(0)(0)(0)(1)(0)1
Income (loss) before gain (loss) on sale of properties:(6)(6)(5)(6)(5)(4)9
Other undisclosed net loss(0) (1)(1) (3)(22)
Net loss:(6)(6)(6)(7)(5)(7)(13)
Net income attributable to noncontrolling interest0000000
Net loss available to common stockholders, diluted:(6)(6)(6)(7)(5)(7)(13)

Comprehensive Income ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
Net loss:(6)(6)(6)(7)(5)(7)(13)
Comprehensive loss:(6)(6)(6)(7)(5)(7)(13)
Comprehensive income, net of tax, attributable to noncontrolling interest0000000
Comprehensive loss, net of tax, attributable to parent:(6)(6)(6)(7)(5)(7)(13)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: